What NASA Said About IBB
What SpaceFraud.Tech Says About IBB
Forget what Melon Musk said about going to Mars in about 45 minutes - he's not going to colonize anyone, anywhere. The only journey Musk is taking is a Voyage to the Center of Melon's Ego and the U.S. Treasury.
E.T. the Enraged Taxpayer should read what NASA said about the problems associated with prolonged employee exposure to microgravity and interstellar radiation: problems that SpaceFraud.Tech deem INSURMOUNTABLE PROBLEMS.
Read on to find out which problems NASA is referring to and WHY SpaceFraud.Tech contends and predicts crew member death or serious injury due to IBB - either during a three-year mission to Mars or after returning to Earth after a three year stint of prolonged exposure to microgravity and interstellar radiation.
What the heck is IBB?
SpaceFraud.Tech coined the term IBB (Insurmountable Biological Barriers) to address the yet-to-be-solved problem of the significant harm and physical damage caused by prolonged human exposure to microgravity and interstellar radiation.
If you think that the problem of IBB is a joke, read NASA astronaut Scott Kelly's personal harrowing diary of the hell he experienced after returning to Earth after spending one year onboard the ISS in 90% of Earth's gravity.
In order for one to understand the serious nature of IBB and the post-effects, harm and damage caused by prolonged exposure to microgravity and radiation, one should read astronaut Kelly's account of IBB sickness and NASA's medical research in this area.
Moreover, please recognize that if "x" represents the amount of physical harm, suffering, temporary and permanent damage caused by one year of employee exposure to microgravity and radiation onboard the ISS in 90% Earth gravity, then one year on the Moon would subject an employee to at least "5x" amount of IBB due to the fact that lunar gravity is only 16.6% of Earth gravity and as such, the harmful and debilitating effects of spending one year on the Moon could likely result in death, serious injury or unrecoverable events that would prevent any return trip to Earth.
NASA is highly cognizant of these IBB risks, yet there goes Melon Musk waxing on about his need for 1,000 TRILLION DOLLARS to colonize Mars.
Interestingly and telling enough, Musk has recently abandoned his plan to colonize the Moon and reinvigorated his claim that he's going to colonize Mars instead.
SpaceFraud.Tech believes Maj. Magic Musk abandoned his Moon colonization claim due to the high level of IBB in lunar gravity on the Moon; whereas Mars gravity is approximately 38% of Earth gravity.
The fact is an employee on Mars would suffer well over twice as much pain, suffering and IBB than an employee onboard the ISS in Earth orbit.
Facts matter more than Melon Musk's childhood Martian dreams of being The Super Ruler of Mars, ala' the 1950's era science-fiction book written by a German Nazi rocket scientist, Dr. Wernher Von Braun who wrote about a human expedition to Mars, whereupon the crew encountered the Great Ruler of Mars, "ELON."
(cue soap opera music here)
You can't make this stuff up, as Errol Musk told his story and explained that once old man Errol impregnated his 19-yr. old step-daughter who Errol raised since she was four years old, she had his baby boy and Papa Errol named it "Elon" after the "ELON" in Errol's favorite science-fiction book, "Das Marsprojekt" (in German language)
Whew. I need a doob, a cup of coffee and a shower.
WHAT NASA SAID AND IS DOING ABOUT IBB
Have you ever heard of NASA's TRISH program? Now you have.
The stated purpose of NASA's TRISH institute is to fund scientific studies and technologies to address and solve IBB - "to help keep astronauts safe and healthy on deep space missions to the Moon, Mars and beyond."
TRISH Research
Deep space exploration – beyond low Earth orbit, to the Moon, Mars, and beyond – presents unique mental, physical, and emotional challenges.
To thrive in deep space, humans will need practical solutions to problems like neurocognitive changes, radiation exposure and other stressors.
TRISH leads a national effort in translating emerging terrestrial biomedical research and technology development into applied human risk-mitigation strategies, helping humans thrive wherever they explore, in space or on Earth.
TRISH funds both early-stage, high-risk research with the potential for high impact as well as more mature, translation-ready technologies that can be employed in spaceflight.
This forward-looking work could create a paradigm shift in healthcare during space exploration enabling us to reach new frontiers in healthcare on Earth.
Translational Research Institute for Space Health Research
TRISH Scientific Initiatives Overview
EXPAND: Advancing Commercial Space Research
As commercial spaceflight takes off, the EXPAND Program seizes new opportunities to study human adaption and physiology. TRISH works with commercial spaceflight providers and their participants to increase engagement in human research and collect essential biomedical data before, during and after spaceflight. This information is securely maintained in the Institute’s centralized EXPAND database, the world’s first and only private space health research repository. It will offer researchers unparalleled access to biological samples and data from a diverse pool of spaceflight participants.
HERMES: A Medical System Architecture
To enable an effective health and performance system, healthcare providers and spaceflight crews need access to current and comprehensive health and performance data to make evidence-based decisions. However, there will be a variety of sources before, during and after a mission that contribute health and performance data creating a fragmented record and inconsistent access. TRISH’s goal is to enable a robust and democratized heath record that accompanies the astronaut making health information and data from a variety of sources useful and accessible, even when the crew is far from Earth.
SENTINEL: Tissue-Chips
TRISH is accelerating human tissue chips system technologies to provide an advanced biological platform to study long-duration deep space exposure. These advanced systems will be automated and have embedded analytic capability allowing researchers to characterize the biological effects of deep space exposure and test personalized countermeasures to protect humans exploring space without requiring samples be returned to Earth for analysis.
Learn more about TRISH scientific initiatives in our Broad Institute Announcement (BIA):
Science ENterprise to INform Exploration Limits (SENTINEL)
NASA’s Artemis missions will place astronauts in lunar orbit and on the lunar surface where they will experience deep space exposure on par with the Apollo missions.
As the mission profiles progress, the Artemis exposure durations will far exceed the prior Apollo experience.
Therefore, it is imperative that the space life science community has the tools to study the effects of long-duration and deep space exposure and test ways to prevent and mitigate its potential negative effects.
The upcoming Artemis missions provide an unprecedented opportunity to understand the risks of deep space exploration as well as approaches to managing those risks.
The Science ENterprise to INform Exploration Limits (SENTINEL) initiative is the TRISH effort to build automated microphysiological systems (MPS; also known as 3D tissue/organ chips) that also have in-line sensing capabilities to self-regulate and provide data to the astronaut crew as well as scientists on the ground thus overcoming the need to return samples to Earth for analysis.
These MPS, tissue or organson–a-chip constructs have the potential to address several knowledge gaps in the impacts of the deep space environment.
This will greatly improve upon the current primary methods of characterizing space exploration risks that use ground analogs and the International Space Station (ISS) providing limited or incomplete translatability and requiring sample return to Earth for analysis for the ISS research.
By using automated and self-reporting MPS, the lunar surface and vicinity can enable critical health and performance studies.
These systems can also be built as single organs or as systems of organs allowing for interactions to simulate responses that might occur within the human body in space.
Successful research and technology development in this area would improve the capability to test the effects of the realistic, deep space radiation environment on a tissue as well as the impacts of medications or other interventions.
In addition, these systems are also being matured and validated with the goal of facilitating personalized and precision medicine.
One can imagine the day when physicians can use cells acquired from a patient to diagnose and test treatments on that individual’s engineered tissues and organs before ever having to introduce more risk to the patient.
This is also the vision for space explorers given the remote, hostile, and austere environment in which they live and work that requires certainty and disciplined risk management.
This approach during the Artemis missions and emerging commercial spaceflight opportunities will allow the MPS payloads to experience deep space exposures similar to those anticipated for exploration class missions and return data throughout the deep space exposure.
Thus, these MPS would enable researchers to conduct time-course, mechanistic and countermeasure development studies while the MPS remain in space.
TRISH plans to advance these state-of-the-art platform capabilities and move towards autonomous systems in upcoming solicitations and projects.
In the future, these tissue chips could be utilized for personalized medicine: with a customized tissue chip of an individual astronaut, sent into deep space before or with an astronaut, thus assisting in the overall assessment of the risks of the space environment on that individual's physiology.
The end goal of the SENTINEL initiative is to provide the space life science research community and ultimately NASA space medicine with effective and reliable
The Human and Environmental Research Matrix for Exploration of Space (HERMES) initiative’s goal is to enable space and ground-based medical teams and systems to monitor and assess crew health status and research study progress even when the astronaut is far from Earth’s surface.
Future missions to the moon and beyond will require multiple vehicles, built and operated by various companies with astronauts transitioning between them on a regular basis, making it challenging to leverage biomedical data management requirements across all vehicles.
Continuity of access to health and performance data is key for safeguarding the astronaut, assessing immediate health and performance risks, and making informed and timely decisions.
The HERMES initiative involves the development of a data acquisition, data ingestion, data management, and data usability framework to support network infrastructure, biomedical peripherals, and end users of the collected data.
HERMES will be developed in phases that started with the initial Human and Environmental Research Matrix for Exploration of Space (HERMES) solicitation to design and build the networking infrastructure to facilitate the movement, storage, and distribution of biomedical data from source to user.
The HERMES funding opportunity solicited for the predominantly software-based, semi-autonomous platform that seamlessly intakes, manages, and moves biomedical data gathered for research and clinical purposes and enables the data to follow the astronaut to any spaceflight venues they visit, whether that be a spacecraft or any other future space destination.
The envisioned platform, when fully completed, will allow continuity across missions and space vehicle operators as astronauts adapt to new space environments.
By aggregating medical, research, environmental, and mission data together and having it follow the crewmember, all the necessary data is aggregated in proximity to the astronaut and available to develop and test autonomous medical systems of the future and allow more seamless remote medical care until autonomy is established.
Topics or Focus Areas of Interest Human and Environmental Research Matrix for Exploration of Space (HERMES) TRISH selected two companies to undertake the initial development of HERMES, TrialX and Ejenta.
Both companies independently developed a robust, scalable, and interoperable network platform that can be used in different spaceflight vehicles that will enable usability and access to a spaceflight participant’s data by algorithmic users, human users on Earth (including clinicians), researchers and the individual themselves.
Develop Artificial Intelligence (AI) and machine learning (ML) Tools Develop artificial intelligence and machine learning tools to begin interpretation of health status information gained through HERMES and made available to crew and doctors on the ground to aid in remote diagnosis of future health concerns of space travelers.
This approach will be especially helpful when astronauts are far from Earth and communication delays exist.
Human and Environmental Research Matrix for Exploration of Space (HERMES)
Help Advance Tissue Chip Research for Space Exploration
Apply with your ideas to improve in-situ measurement technologies for use during future deep space missions, where traditional sample return to Earth may not be feasible.
Researchers: Apply Now to Help Advance Tissue Chip Research for Space Exploration
The NASA-funded Translational Research Institute for Space Health (TRISH) is now accepting research proposals to advance remote biomarker analysis capabilities in microphysiological systems (MPS), also known as tissue chips, for space exploration.
What are we seeking?
This solicitation seeks innovative solutions to improve in-situ measurement technologies for use during future deep space missions, where traditional sample return to Earth may not be feasible.
This solicitation falls under TRISH’s SENTINEL (Science ENterprise to INform Exploration Limits) program. By advancing the MPS platform, TRISH aims for a new way to gather personalized astronaut data without needing a researcher on Earth to tend the physical samples.
Proposals for this solicitation focus on technologies capable of analyzing a wide range of biomarkers, bioindicators, or biosignatures without requiring sample return. TRISH is prioritizing methods that are non-invasive, that do not destroy the sample, and that allow for data collection over multiple timepoints separated by days or weeks. Such systems should be adaptable and not restricted to specific laboratory setups. In addition to biomarkers, proposers may address environmental factors, cell function, and tissue health in advanced biological constructs.
If you have a research idea that fits with this open solicitation, follow the steps below to submit a proposal for this Remote Biomarker Measurements in Microphysiological Systems opportunity:
Learn about TRISH’s SENTINEL initiative.
Read this solicitation, which requires a full proposal to be considered. Please refer to the solicitation for submission requirements.
Watch the pre-proposal webinar recording via the solicitation available on TRISH’s GRID (Grant Research Integrated Dashboard).
Submit a proposal through GRID. Proposers must submit a full proposal for TRISH to review. Proposers considering applying must register in the system for award management (SAM) database (www.sam.gov) to ensure ability to receive funds if selected.
Who can submit a proposal? All categories of U.S. institutions and companies are eligible to submit proposals. Principal investigators may collaborate with universities, the private sector, and federal, state, and local government laboratories. Please visit the Remote Biomarker Measurements in Microphysiological Systems solicitation for full details.
Research Duration: One year.
Award: Projects can reach a total amount of $400,000.
Resources: For more details, watch a pre-proposal webinar recording, which is available via the solicitation here.
Deadline: Full proposals are due 11:59 p.m. ET on March 6, 2025.
Background on TRISH: TRISH is a virtual institute empowered by the NASA Human Research Program to help solve challenges of human deep space exploration. TRISH pursues and funds research to deliver scientific and technological solutions that advance space health and help humans thrive wherever they explore, in space or on Earth. Learn more about TRISH.
Questions? Follow the link here for a form and select “open solicitation” to submit questions.
Tissue Chips
TRISH is accelerating its use of human microphysiological systems, or tissue chips, to study long-duration exposures to deep space radiation as part of its Science Enterprise to Inform Exploration Limits (SENTINEL) program. Tissue chips enable researchers to grow cells and tissues outside of the human body and characterize the biological effects of deep space exposure.
Objective Reality and Taxpayer-funded Human Colonization Projects on Other Planets
SpaceFraud.Tech contends that any objective professional cost-to-benefit analysis of U.S. taxpayer-funded space programs related to or in preparation for what NASA and SpaceX calls the human colonization of the Moon and Mars, finds that such multi-trillion dollar expenditures are quite simply not worth it and will incur even greater cost to U.S. taxpayers than advertised, due to the likelihood of mission failure, crew death or near fatal injury as a result of prolonged exposure to microgravity and deep space interstellar radiation.
SpaceFraud.Tech contends that
SpaceFraud.Tech contends that
SpaceFraud.Tech predicts the future
The Honest-to-God truth about any claim of human colonization of Mars, much less the Moon, is that over fifty years of NASA medical research on the harmful, debilitating effects of prolonged exposure to microgravity and radiation conclusively indicates that human colonization is not physically possible due to the insurmountable human biological barrier of reverse blood and fluid flow in the human cranium and body.
Find out for yourselves:
At least NASA is very well aware of these longstanding human biological barriers to human colonization of Mars and the Moon; and that's why NASA is seeking bids on NASA contracts to solve this most pivotal, central, primary insurmountable barrier to three year missions to Mars or any prolonged human exposure to microgravity and interstellar radiation.
Melon Musk conducts himself and his business AS IF, AS IF, AS IF MELON MUSK HAD ALREADY SOLVED THESE INSURMOUNTABLE PROBLEMS that NASA recognizes as current insurmountable barriers NASA is desperately trying to solve.
Recognize the simple fact that after 50 years of NASA medical research into the insurmountable barrier of reverse blood and fluid flow and the damage it causes, NASA has yet to solve what SpaceFraud.Tech refers to as "INSURMOUNTABLE BIOLOGICAL BARRIERS" to human colonization on Mars or the Moon. (IBB - Insurmountable Biological Barriers)
